Advanced search
Publication Cover
OncoTargets and Therapy Volume 10, 2017 - Issue
Submit an article Journal homepage
135
Views
35
CrossRef citations to date
0
Altmetric
Original Research

Improvement of survival for non-small cell lung cancer over time

Wenjie Xia1 Department of Thoracic Surgery, Nanjing Medical University Affiliated Cancer Hospital;2 Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Cancer Institute of Jiangsu Province;3 The Fourth Clinical College of Nanjing Medical University
,
Xinnian Yu4 Department of Chemotherapy, Nanjing Medical University Affiliated Cancer Hospital Cancer Institute of Jiangsu Province
,
Qixing Mao1 Department of Thoracic Surgery, Nanjing Medical University Affiliated Cancer Hospital;2 Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Cancer Institute of Jiangsu Province;3 The Fourth Clinical College of Nanjing Medical University
,
Wenying Xia5 Department of Laboratory Medicine, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China
,
Anpeng Wang1 Department of Thoracic Surgery, Nanjing Medical University Affiliated Cancer Hospital;2 Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Cancer Institute of Jiangsu Province;3 The Fourth Clinical College of Nanjing Medical University
,
Gaochao Dong1 Department of Thoracic Surgery, Nanjing Medical University Affiliated Cancer Hospital;2 Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Cancer Institute of Jiangsu Province
,
Bing Chen1 Department of Thoracic Surgery, Nanjing Medical University Affiliated Cancer Hospital;2 Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Cancer Institute of Jiangsu Province;3 The Fourth Clinical College of Nanjing Medical University
,
Weidong Ma1 Department of Thoracic Surgery, Nanjing Medical University Affiliated Cancer Hospital;2 Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Cancer Institute of Jiangsu Province;3 The Fourth Clinical College of Nanjing Medical University
,
Lin Xu1 Department of Thoracic Surgery, Nanjing Medical University Affiliated Cancer Hospital;2 Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Cancer Institute of Jiangsu ProvinceCorrespondence[email protected] [email protected]
&
Feng Jiang1 Department of Thoracic Surgery, Nanjing Medical University Affiliated Cancer Hospital;2 Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Cancer Institute of Jiangsu ProvinceCorrespondence[email protected] [email protected]
 show all
Pages 4295-4303 | Published online: 29 Aug 2017

Citations (35)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Noori Akhtar-Danesh, Gileh-Gol Akhtar-Danseh, Hsien Yeang Seow, Saad Shakeel & Christian Finley. (2019) Trends in Survival Based on Treatment Modality in Non-Small Cell Lung Cancer Patients: A Population-Based Study. Cancer Investigation 37:8, pages 355-366.
Read now
Danilo Rocco, Luigi Della Gravara, Ciro Battiloro & Cesare Gridelli. (2019) The role of combination chemo-immunotherapy in advanced non-small cell lung cancer. Expert Review of Anticancer Therapy 19:7, pages 561-568.
Read now

Articles from other publishers (33)

Tamta Makharadze, Ruben G. W. Quek, Tamar Melkadze, Miranda Gogishvili, Cristina Ivanescu, Davit Giorgadze, Mikhail Dvorkin, Konstantin Penkov, Konstantin Laktionov, Gia Nemsadze, Marina Nechaeva, Irina Rozhkova, Ewa Kalinka, Christian Gessner, Brizio Moreno‐Jaime, Rodolfo Passalacqua, Gerasimos Konidaris, Petra Rietschel & Giuseppe Gullo. (2023) Quality of life with cemiplimab plus chemotherapy for first‐line treatment of advanced non–small cell lung cancer: Patient‐reported outcomes from phase 3 EMPOWER‐Lung 3. Cancer 129:14, pages 2256-2265.
Crossref
Nur Swaleh Said & Amsalu Degu. (2023) Assessment of survival outcomes among lung cancer patients at the National and Referral Hospital in Kenya. Cancer Medicine 12:8, pages 9194-9201.
Crossref
Akira Sato, Toshitaka Morishima, Masato Takeuchi, Kayo Nakata, Koji Kawakami & Isao Miyashiro. (2023) Survival in non-small cell lung cancer patients with versus without prior cancer. Scientific Reports 13:1.
Crossref
Vladimir Jurisic, Jasmina Obradovic, Nadja Nikolic, Jovan Javorac, Branislav Perin & Jelena Milasin. (2022) Analyses of P16INK4a gene promoter methylation relative to molecular, demographic and clinical parameters characteristics in non-small cell lung cancer patients: A pilot study. Molecular Biology Reports 50:2, pages 971-979.
Crossref
Hiroaki TERAMATSU, Hiroshi YAMATO, Ying JIANG, Hiroaki KAKO, Satoshi KUHARA, Ryosuke OHYA, Hideaki ITOH, Koji KURODA, Yasuyuki MATSUSHIMA & Satoru SAEKI. (2022) Pre-operative Physical Performance Is Associated With Early Return to Work in Peri-operative Lung Cancer Patients肺がん手術後の早期復職と術前身体能力との関連. Journal of UOEH 44:4, pages 341-351.
Crossref
Feredun Azari, Gregory Kennedy, Ashley Chang, Bilal Nadeem, Neil Sullivan, Isvita Marfatia, Azra Din, Charuhas Desphande, John Kucharczuk, Edward J. Delikatny & Sunil Singhal. (2022) Presence of non-Newtonian fluid in invasive pulmonary mucinous adenocarcinomas impacts fluorescence during intraoperative molecular imaging of lung cancer. European Journal of Nuclear Medicine and Molecular Imaging 49:13, pages 4406-4418.
Crossref
HyacinthN Highland, MonicaB Thakur & Linz-Buoy George. (2022) Controlling non small cell lung cancer progression by blocking focal adhesion kinase-c-Src active site with Rosmarinus officinalis L. phytocomponents: An in silico and in vitro study. Journal of Cancer Research and Therapeutics 18:6, pages 1674.
Crossref
Carlos Gil Ferreira, Marcia Datz Abadi, Paula de Mendonça Batista, Fernando Brandão Serra, Rodrigo Buzzatti Peixoto, Lucas Miyake Okumura & Erica Regina Cerqueira. (2021) Demographic and Clinical Outcomes of Brazilian Patients With Stage III or IV Non–Small-Cell Lung Cancer: Real-World Evidence Study on the Basis of Deterministic Linkage Approach. JCO Global Oncology:7, pages 1454-1461.
Crossref
Jason Gordon, Angela Stainthorpe, Beverley Jones, Ian Jacob, Nadine Hertel, Jose Diaz, Yong Yuan & John Borrill. (2021) Non-Price-Related Determinants of Value and Access for Novel Non-small Cell Lung Cancer Treatments: A Cross-Country Review of HTA Decision Making. PharmacoEconomics - Open 5:4, pages 701-713.
Crossref
Michael S. Ewer & Steven M. Ewer. (2021) Perspective on the Cardiotoxicity of Third-Generation Targeted EGFRs in the Treatment of NSCLC. JTO Clinical and Research Reports 2:10, pages 100233.
Crossref
Humayra Rashid, Martin Eichler, Marlene Hechtner, Emilio Gianicolo, Beatrice Wehler, Roland Buhl, Heinz Schmidberger, Jan A. Stratmann, Bernhard Gohrbandt, Cornelius Kortsik, Ursula Nestle, Hubert Wirtz, Maria Blettner & Susanne Singer. (2020) Returning to work in lung cancer survivors—a multi-center cross-sectional study in Germany. Supportive Care in Cancer 29:7, pages 3753-3765.
Crossref
Hyoungmin Kim, Sam Yeol Chang, Jongyeon Son, Sujung Mok, Sung Cheol Park & Bong-Soon Chang. (2021) The Effect of Adding Biological Factors to the Decision-Making Process for Spinal Metastasis of Non-Small Cell Lung Cancer. Journal of Clinical Medicine 10:5, pages 1119.
Crossref
Eric Nadler, Bhakti Arondekar, Kathleen Marie Aguilar, Jie Zhou, Jane Chang, Xinke Zhang & Vivek Pawar. (2020) Treatment patterns and clinical outcomes in patients with advanced non-small cell lung cancer initiating first-line treatment in the US community oncology setting: a real-world retrospective observational study. Journal of Cancer Research and Clinical Oncology 147:3, pages 671-690.
Crossref
Avinash R Chaurasia, John White, Robert C Beckmann, Michael Chamberlin, Adam Horn, Anna M Torgeson, William Skinner, Delnora Erickson & Aaron Reed. (2021) Early-Stage Non-Small Cell Lung Cancer Stereotactic Body Radiation Therapy (SBRT) Outcomes in an Equal Access Military Setting. Cureus.
Crossref
Ryan N. Hansen, Yiduo Zhang, Brian Seal, Kellie Ryan, Candice Yong, Annie Darilay & Scott D. Ramsey. (2020) Long-term survival trends in patients with unresectable stage III non-small cell lung cancer receiving chemotherapy and radiation therapy: a SEER cancer registry analysis. BMC Cancer 20:1.
Crossref
James Monkman, Touraj Taheri, Majid Ebrahimi Warkiani, Connor O’Leary, Rahul Ladwa, Derek Richard, Ken O’Byrne & Arutha Kulasinghe. (2020) High-Plex and High-Throughput Digital Spatial Profiling of Non-Small-Cell Lung Cancer (NSCLC). Cancers 12:12, pages 3551.
Crossref
Venus Zafari, Habib Zarredar, Elham Poursaei, Mahsa Abolghasemi, Dariush Shanehbandi, Soghra Bornehdeli, Milad Asadi & Akbar Sharifi. (2020) Evaluating of miR-184, miR-497, miR-378, miR-103 and miR-506 expression level in non-small cell lung cancer patients tissues compared with their normal marginal tissues. Gene Reports 20, pages 100750.
Crossref
Christina A. Clarke, Earl Hubbell, Allison W. Kurian, Graham A. Colditz, Anne-Renee Hartman & Scarlett Lin Gomez. (2020) Projected Reductions in Absolute Cancer–Related Deaths from Diagnosing Cancers Before Metastasis, 2006–2015. Cancer Epidemiology, Biomarkers & Prevention 29:5, pages 895-902.
Crossref
Rajagopal Anitha, Rajakannu Subashini & Ponnusamy Senthil Kumar. (2020) In silico and in vitro approaches to evaluate the bioactivity of Cassia auriculata L extracts . IET Nanobiotechnology 14:3, pages 210-216.
Crossref
Abbie Begnaud, Ping Yang, Camille Robichaux, Nathan Rubin, Robert Kratzke, Anne Melzer, Constantin Aliferis & Pamala Jacobson. (2020) Evidence That Established Lung Cancer Mortality Disparities in American Indians Are Not Due to Lung Cancer Genetic Testing and Targeted Therapy Disparities. Clinical Lung Cancer 21:3, pages e164-e168.
Crossref
Noorwati Soetandyo, Arif Riswahyudi Hanafi, Sri Agustini & Dian Triana Sinulingga. (2020) Prognosis of advanced stage non-small-cell lung cancer patients receiving chemotherapy: adenocarcinoma <em>versus</em> squamous cell carcinoma. Medical Journal of Indonesia 29:1, pages 26-31.
Crossref
Julien Mazieres, Dariusz Kowalski, Alexander Luft, David Vicente, Ali Tafreshi, Mahmut Gümüş, Konstantin Laktionov, Barbara Hermes, Irfan Cicin, Jerónimo Rodríguez-Cid, Jonathan Wilson, Terufumi Kato, Rodryg Ramlau, Silvia Novello, Sreekanth Reddy, Hans-Georg Kopp, Bilal Piperdi, Xiaodong Li, Thomas Burke & Luis Paz-Ares. (2020) Health-Related Quality of Life With Carboplatin-Paclitaxel or nab-Paclitaxel With or Without Pembrolizumab in Patients With Metastatic Squamous Non–Small-Cell Lung Cancer. Journal of Clinical Oncology 38:3, pages 271-280.
Crossref
Pranjal Kumar, Seema Khadirnaikar & Sudhanshu Kumar Shukla. (2019) A novel LncRNA‐based prognostic score reveals TP53‐dependent subtype of lung adenocarcinoma with poor survival. Journal of Cellular Physiology 234:9, pages 16021-16031.
Crossref
Bonggun Shin, Sungsoo Park, Ji Hyung Hong, Ho Jung An, Sang Hoon Chun, Kilsoo Kang, Young-Ho Ahn, Yoon Ho Ko & Keunsoo Kang. (2019) Cascaded Wx: A Novel Prognosis-Related Feature Selection Framework in Human Lung Adenocarcinoma Transcriptomes. Frontiers in Genetics 10.
Crossref
Hironori Kawamoto, Hiromichi Hara, Jun Araya, Akihiro Ichikawa, Yu Fujita, Hirofumi Utsumi, Mitsuo Hashimoto, Hiroshi Wakui, Shunsuke Minagawa, Takanori Numata, Seiji Arihiro, Tomokazu Matsuura, Mutsunori Fujiwara, Satoru Ito & Kazuyoshi Kuwano. (2019) Prostaglandin E-Major Urinary Metabolite (PGE-MUM) as a Tumor Marker for Lung Adenocarcinoma. Cancers 11:6, pages 768.
Crossref
Yi Xin, Xin Huang, Zengbei Li, Wenfei Zhao, Chunlin Wang, Shaobo Wang, Xianyang Yue, Hui Mo & Hongyun Li. (2019) Versatile Pt NCs-based chemotherapeutic agents significantly induce the apoptosis of cisplatin-resistant non-small cell lung cancer. Biochemical and Biophysical Research Communications 512:2, pages 218-223.
Crossref
Katherine C. Kurnit, Shannon N. Westin & Robert L. Coleman. (2019) Microsatellite instability in endometrial cancer: New purpose for an old test. Cancer.
Crossref
Bishal Gyawali, Gauthier Bouche, Pan Pantziarka, Aaron S. Kesselheim & Ameet Sarpatwari. (2021) Lung Cancer Survival Gains: Contributions of Academia and Industry. Journal of Law, Medicine & Ethics 47:3, pages 465-467.
Crossref
Ha Na Gil, Euitaek Jung, Dongsoo Koh, Yoongho Lim, Young Han Lee & Soon Young Shin. (2019) A synthetic chalcone derivative, 2-hydroxy-3′,5,5′-trimethoxychalcone (DK-139), triggers reactive oxygen species-induced apoptosis independently of p53 in A549 lung cancer cells. Chemico-Biological Interactions 298, pages 72-79.
Crossref
Sendhilnathan Ramalingam, Michaela A. Dinan & Jeffrey Crawford. (2018) Survival Comparison in Patients with Stage IV Lung Cancer in Academic versus Community Centers in the United States. Journal of Thoracic Oncology 13:12, pages 1842-1850.
Crossref
Yuanyuan Hu, Jie Shen, RuiKe Liu, ZhiMei Feng, ChangNing Zhang, Li Ling & LiBo Chen. (2018) Prognostic value of pretreatment prognostic nutritional index in non-small cell lung cancer: A systematic review and meta-analysis. The International Journal of Biological Markers 33:4, pages 372-378.
Crossref
Dhaval Sanchala, Lokesh Kumar Bhatt, Prasad Pethe, Ruchita Shelat & Yogesh A. Kulkarni. (2018) Anticancer activity of methylene blue via inhibition of heat shock protein 70. Biomedicine & Pharmacotherapy 107, pages 1037-1045.
Crossref
Nikhil Yegya-Raman, Kyle Wang, Sinae Kim, Meral Reyhan, Matthew P. Deek, Mutlay Sayan, Diana Li, Malini Patel, Jyoti Malhotra, Joseph Aisner, Lawrence B. Marks & Salma K. Jabbour. (2018) Dosimetric Predictors of Symptomatic Cardiac Events After Conventional-Dose Chemoradiation Therapy for Inoperable NSCLC. Journal of Thoracic Oncology 13:10, pages 1508-1518.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.